DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moridani, M. Y.
Right arrow Articles by O'Brien, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moridani, M. Y.
Right arrow Articles by O'Brien, P. J.

Vol. 29, Issue 11, 1432-1439, November 2001


Caffeic Acid, Chlorogenic Acid, and Dihydrocaffeic Acid Metabolism: Glutathione Conjugate Formation

Majid Y. Moridani, Hugh Scobie, Akram Jamshidzadeh, Par Salehi, and Peter J. O'Brien

Faculty of Pharmacy, University of Toronto, Ontario, Canada


    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The antioxidant properties of the dietary dihydroxycinnamic acids [caffeic (CA), dihydrocaffeic (DHCA), and chlorogenic (CGA) acids] have been well studied but little is known about their metabolism. In this article, evidence is presented showing that CA, DHCA, and CGA form quinoids and hydroxylated products when oxidized by peroxidase/H2O2 or tyrosinase/O2. Mass spectrometry analyses of the metabolites formed with peroxidase/H2O2/glutathione (GSH) revealed that mono- and bi-glutathione conjugates were formed for all three compounds except CGA, which formed a bi-glutathione conjugate only when GSH was present. In contrast, the metabolism of the dihydroxycinnamic acids by tyrosinase/O2/GSH resulted in the formation of only mono-glutathione conjugates. In the absence of GSH, hydroxylated products and p-quinones of CA or CGA were formed by peroxidase/H2O2. DHCA formed a hydroxylated adduct (even though GSH was present), as well as the corresponding p-quinone and dihydroesculetin, an intramolecular cyclization product. NADPH also supported rat liver microsomal-catalyzed CA-, CGA-, and DHCA-glutathione conjugate formation, which was prevented by benzylimidazole, a cytochrome P450 inhibitor. Furthermore, the cytotoxicity of CA, CGA, and DHCA toward isolated rat hepatocytes was markedly enhanced by hydrogen peroxide or cumene hydroperoxide-supported cytochrome P450 and was prevented by benzylimidazole. Cytotoxicity was also markedly enhanced by dicumarol, an NADPH/oxidoreductase inhibitor. These results suggest that dihydroxycinnamic acids were metabolically activated by P450 peroxidase activity to form cytotoxic quinoid metabolites.


    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Chlorogenic acid (CGA)1, caffeic acid (CA), and dihydrocaffeic acid (DHCA) are nonflavonoid catecholic compounds, which are present in many plants (Fig. 1). These chemicals are present in the diet as part of fruits, tea, coffee, and wine (Buren et al., 1973; Challis and Bartlett, 1975). There is growing interest in the multiple biological and pharmacological properties of nonflavonoid catecholic compounds, such as CGA, CA, and DHCA (dihydroxycinnamic acids) (Laranjinha et al., 1994). It has been reported that these catecholic acids have anti-inflammatory, antimutagenic, and anticarcinogenic activities (Challis and Bartlett, 1975; Koshihara et al., 1984; Tanaka et al., 1993a,b). The focus of much of the current research is on their cancer chemoprevention and antioxidant properties (Challis and Bartlett, 1975; Koshihara et al., 1984; Tanaka et al., 1993a,b; Laranjinha et al., 1995; Nardini et al., 1995). However, there is little information available in the literature on the enzymatic oxidation of CGA, CA, and DHCA.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   Chemical structures of dietary dihydroxycinnamic acids.

An example of enzyme-directed antimelanoma therapy includes the bioactivation of a phenolic or a catecholic agent to an o-quinone by tyrosinase-containing tumor cells (Riley et al., 1997). An agent that can undergo tyrosinase-mediated oxidation to generate a cytotoxic reactive intermediate species, such as o-quinone, but is not metabolically activated by P450-rich-containing tissues, such as liver or kidneys, would be an ideal candidate for an antimelanoma therapy trail. In search of such a candidate we have investigated the enzymatic oxidation of dihydroxycinnamic acids by three different metabolizing systems, i.e., horseradish peroxidase type I (HRP)/H2O2 and tyrosinase/O2 or rat liver microsomal P450/NADPH systems.

We previously used tandem mass spectrometry, HPLC, and UV spectroscopy to show that quercetin and other flavonoid compounds formed glutathione conjugates by HRP/H2O2 and tyrosinase/O2 (Galati et al., 1999, 2001). In this article, we have used similar techniques to show that CA, DHCA, and CGA underwent an enzymatic oxidation by HRP/H2O2 or tyrosinase/O2 to form a transient o-quinone intermediate that formed a conjugate with glutathione or underwent hydroxylation by H2O. Further oxidation of this hydroxylated adduct by O2 formed a p-quinone.

Glutathione conjugate formation also occurred when these dihydroxycinnamic acids were metabolized by an NADPH/rat liver microsomes system. Conjugate formation was prevented by benzylimidazole, a cytochrome P450 inhibitor. Dicumarol (an NADPH/oxidoreductase inhibitor) increased hepatocyte cytotoxicity induced by these dihydroxycinnamic acids, whereas benzylimidazole prevented cytotoxicity. This suggests that dihydroxycinnamic acids were metabolically activated by cytochrome P450 to form cytotoxic-reactive quinoid intermediates.



    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Chemicals. CGA, DHCA, CA, mushroom tyrosinase, horseradish peroxidase, hydrogen peroxide, magnesium chloride, potassium borohydride, ethyl acetate, NADP+, glucose 6-phosphate, glucose-6-phosphate dehydrogenase, glucose, glucose oxidase, cumene hydroperoxide, sodium azide, sodium periodate, benzylimidazole, glutathione (reduced), Tris, diethylenetriaminepentaacetic acid (DETAPAC), potassium phosphate monobasic, potassium phosphate dibasic, 5,5'-dithio-bis(2-nitrobenzoic acid), dimethyl sulfoxide, trichloroacetic acid, and 3-(N-morpholino)propanesulfonic acid were obtained from Sigma-Aldrich (Oakville, ON, Canada). The stock solutions of dihydroxycinnamic acids were prepared in dimethyl sulfoxide. Other chemicals were prepared in Millipore filtered water (Millipore Corporation, Bedford, MA) or buffer. The stock solution of DTNB was dissolved in Tris/HCl buffer (0.1 M, pH 8.9, containing 1 mM DETAPAC). All concentrations shown were final concentrations.

Preparation of 4-Propylcatechol. 4-Propylcatechol was prepared according to the method described by Bolton et al. (1994) and Iverson et al. (1995).

Oxidation Studies by UV-VIS Spectroscopy. The spectra of solutions containing 50 to 100 µM CGA, DHCA, and CA were recorded in the absence and presence of glutathione before or after the addition of HRP (0.1 or 3 µM)/H2O2 (50 µM) or tyrosinase (25 units/ml) in a potassium phosphate buffer (50 mM, pH 6.0, containing 1 mM DETAPAC). An Amersham Pharmacia Biotech Ultraspec 1000 (Piscataway, NJ) with the proprietary Swift 1000 software was used to record data.

o-Quinone Stability Kinetics. Sodium periodate (250 µM) was added to a solution of CA, DHCA, or CGA (250 µM) in 3 ml of sodium phosphate buffer at various pH (4.0, 5.0, 6.0, or 7.4). The absorbance was monitored at 420 nm over a period of 20 min.

Dihydroxycinnamic Acids Oxidation Kinetics. The rate of oxygen consumption was measured for auto-oxidation in a sealed chamber containing dihydroxycinnamic acids (500 mM) in phosphate buffer (0.1 M, pH 7.4, containing 1 mM DETAPAC) by a Clark-type O2 electrode. The initial oxygen concentration was determined as 224 nmol/ml at standard temperature and pressure (Umbreit et al., 1964).

For tyrosinase enzymatic-mediated oxidation rate measurement, tyrosinase (25 units/ml) was added to a solution of dihydroxycinnamic acids (250 µM) in the presence or absence of GSH (1 mM) in phosphate buffer (0.1 M, pH 7.4, containing 1 mM DETAPAC), and the rate of oxygen consumption was measured by a Clark type O2 electrode.

The rate of o-quinone formation was followed spectrophotometrically at 420 nm for chemical oxidation (by H2O2 or cumene hydroperoxide) or HRP/H2O2 enzymatic-mediated oxidation of dihydroxycinnamic acids. Hydrogen peroxide (2 mM) or HRP (0.01 µM)/H2O2 (500 µM) was added to a solution of dihydroxycinnamic acid (250 µM) in phosphate buffer (0.1 M, pH 7.4, containing 1 mM DETAPAC). Cumene hydroperoxide (130 µM) was added to a solution of dihydroxycinnamic acid (250 µM) in methanol (20%, v/v)/phosphate buffer (0.1 M, pH 7.4, containing 1 mM DETAPAC).

Distribution Coefficient Value. Phosphate buffer (50 mM, pH 4.0, containing 1 mM DETAPAC) was prepared and presaturated with 1-octanol overnight. Aliquots of 5 to 10 ml of 1-octanol (which was mutually presaturated with phosphate buffer) were added to the phosphate buffer containing CGA, CA, or DHCA (100 µM). The octanol was added in time intervals of 30 min during which the solution was constantly stirred. The absorbance of the aqueous solution was monitored at both 300 and 325 nm for CGA and CA, and 280 nm for DHCA before and after each octanol addition. All solutions were prepared and used at room temperature.

The distribution coefficient value of the neutrally charged dihydroxycinnamic acid fraction between the two phases was calculated from Dpart = [(A1 - A2)/A2 × Vw/Vo], where Dpart is the distribution coefficient value at pH 4.0. A1 and A2 are the absorbance of the aqueous phase before and after the addition of 1-octanol, respectively. Vw and Vo are the volumes of the aqueous and 1-octanol phases, respectively. Log P was calculated from P = Dpart/(1 - alpha ) where P, alpha , and Dpart are partition coefficient, degree of ionization at pH 4.0, and distribution coefficient at pH 4.0, respectively.

Glutathione Depletion Assay. HRP (0.1 µM) and H2O2 (50 µM) were added to a mixture containing dihydroxycinnamic acids (50 µM) and glutathione (200 µM) in 1 ml of sodium phosphate buffer (0.1 M, pH 4.0, containing 1 mM DETAPAC). The mixture was preincubated for 30 min from which 250 µl was added to 25 µl of 30% w/v trichloroacetic acid, vortexed, and left for 5 min. An aliquot of 100 µl of the supernatant was added to a solution containing 25 µl of 2 mg/ml DTNB (prepared in Tris/HCl buffer, 0.1 M, pH 8.9) and 875 µl of Tris/HCl buffer (0.1 M, pH 8.9) and vortexed. The absorbances of the solutions were monitored at 412 nm for CA and DHCA and at 460 nm for CGA. The glutathione depletion assay for CGA, DHCA, and CA was also carried out with tyrosinase (20 units/ml) at pH 4.0.

Mass Spectrometry Analyses. The reaction mixtures contained CGA, CA, or DHCA (1 mM) and GSH (4 mM) in 1 ml of Millipore filtered water to which was added HRP (3 µM)/H2O2 (2 mM) or tyrosinase (25 units/ml). The reactions were incubated for 5 min at room temperature prior to direct injection into a mass spectrometer (PE Sciex III, Biomolecular Mass; PE Sciex, Toronto, ON, Canada). Mass spectrometry analysis was also performed when GSH was added to the reaction mixture 5 min after HRP/H2O2 or tyrosinase addition.

Glutathione Conjugate Formation by Rat Hepatocyte Microsomes. Adult male Sprague-Dawley rats, 250 to 300 g, were obtained from Charles River Canada Laboratories (Montreal, QC, Canada), fed ad libitum, and allowed to acclimatize for 1 week on clay chip bedding. The animals were anesthetized by sodium pentobarbital (60 mg/kg of body weight). Livers were removed under sterile potassium buffer/KCl solution (1.18%, w/v, 4°C) as previously described (Anari et al., 1997a). Hepatic microsomes were prepared as described by Dallner (1978).

Glucose 6-phosphate (7.5 mM) was added to a mixture of the test compound (0.5 mM), NADP+ (0.5 mM), magnesium chloride (5 mM), microsomes (1 mg/ml), and glucose-6-phosphate dehydrogenase (2.5 units/ml), in 1 ml Tris/HCl buffer (0.1 M, pH 7.4, containing 1 mM DETAPAC). GSH concentration was 0.5 mM when it was present. The mixture was preincubated at 37°C from which 250-µl samples were taken at 30 and 60 min and added to 25 µl of 30% w/v trichloroacetic acid, vortexed, left for 5 min, and centrifuged to discard the protein pellet. An aliquot of 62.5 µl of 2 mg/ml DTNB (prepared in Tris/HCl buffer, pH 8.94) was added to 100 µl of the supernatant. The absorbance was monitored at 412 nm for CA and DHCA and at 460 nm for CGA. The assay was repeated in the presence of benzylimidazole (300 µM final concentration) as a P450 inhibitor.

Isolated Rat Hepatocyte Cytotoxicity Studies. Hepatocytes (10 ml) (106 cells/ml) were preincubated at 37°C under an atmosphere of 95% O2 and 5% CO2 in Krebs-Henseleit buffer, pH 7.4, with CA (5 mM), 4-propylcatechol (0.3 mM), dihydrocaffeic acid (5 mM), and chlorogenic acid (5 mM). Where shown the following inhibitors were used: 100 µM benzylimidazole (a P450 inhibitor; Quan et al., 1992), 20 µM dicumarol (an NADPH/quinone oxidoreductase inhibitor; Preusch et al., 1991), 4 mM sodium azide (a catalase inhibitor), and 200 µM bromoheptane (a GSH-depleting agent; Khan and O'Brien, 1991). Catalytic agents used included hydrogen peroxide (10 mM glucose/1 unit/ml glucose oxidase) or cumene hydroperoxide (130 µM), or tyrosinase (100 units/ml) in the presence or absence of benzylimidazole (100 µM). Cell viability at 60, 120, and 180 min of incubation was determined by trypan blue uptake. None of the inhibitors or catalytic agents affected the viability of control hepatocytes at the concentrations used. Three separate experiments were carried out. Values shown are means ± S.E.

The rate of hydrogen peroxide generated by glucose/glucose oxidase system was determined using a Clark type oxygen electrode.

HPLC Analysis of GSH and GSSG Contents of Isolated Rat Hepatocytes. A modified method reported by Reed et al. (1980) was used for the HPLC analysis of GSH and GSSG. An 800-µl aliquot of the isolated rat hepatocytes reaction mixture was added to 200 µl of 25% w/v metaphosphoric acid in a glass tube, vortexed, left for 30 min at room temperature, and centrifuged. A 500-µl aliquot of the supernatant and 50 µl of 15 mg/ml freshly prepared iodoacetic acid in water were cotransferred to a glass tube containing sodium bicarbonate (~100-200 mg), vortexed, left up to 1 h or overnight at room temperature in a dark room. To this was then added 500 µl of 1.5% w/v 2,4-dinitro-fluorobenzene (prepared in ethanol), which was vortexed and left to stand at room temperature in a dark room for a period of 4 to 6 h for immediate HPLC processes.

An autoinjector (WISP 710B; Waters Scientific Ltd., Milford, MA) was used to inject a 50-µl sample of the reaction mixture into an HPLC column [µBondapak NH2 (aminopropylsilyl bonded amorphous silica) 125Å, 10 µM, 3.9 × 300 mm; Waters Scientific Ltd.). The gradient mobile phase used to elute the sample comprised two solvent systems: solvent A, methanol/water 80:20; and solvent B, methanol/acetate buffer 80:20. Acetate buffer was prepared by the addition of sodium acetate trihydrate (270 g) and acetic acid glacial (378 ml) to Millipore water (128 ml). The HPLC pump (model 501; Waters Scientific Ltd.) was programmed at a flow rate of 1 ml/min for the mobile phase A/B with ratio of 90:10 (0 min), 10:90 (25 min), 90:10 (27 min), and 90:10 (30 min). The LC spectrophotometer (Lambada-Max, model 481; Waters Scientific Ltd.) was set at 365 nm to detect GSH and GSSG, with retention times of 17.5 and 20.5 min, respectively. Software (Maxima 820 chromatography workstation version 3.30; Dynamic Solutions, a division of Millipore Corporation) and an IBM compatible computer were used for analysis of the data and integration.



    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Oxidation Studies by UV-VIS Spectroscopy. There were varying rates of oxidation for dihydroxycinnamic acids by HRP/H2O2 or tyrosinase/O2-oxidizing systems (Table 1). DHCA was found to possess the lowest rate of oxidation by HRP/H2O2 but had the fastest rate of oxidation by tyrosinase and oxygen. CGA and CA, on the other hand, were more rapidly oxidized by HRP/H2O2 than tyrosinase/O2.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1
Kinetic data for dihydroxycinnamic acid autooxidation, chemical oxidation, and enzymatic oxidation and the t1/2 stability for the o-quinones formed

UV-VIS spectroscopy of the CGA solution showed a distinct peak at 325 nm with a characteristic shoulder at 295 nm, whereas CA had a double peak at 285 and 310 nm. DHCA, which lacked the double bond in its side chain, demonstrated a single peak at 280 nm (Table 2). In the presence of HRP/H2O2 or tyrosinase/O2 at pH 4.0, CA, CGA, and DHCA formed a new peak at 420 nm that was extractable with ethyl acetate. In addition, CGA and CA showed a large peak at 250 nm with a shoulder at 260 nm, whereas DHCA displayed an increase in its peak absorbance at 280 nm. CGA, CA, and DHCA oxidation by HRP/H2O2 formed a product at 260 nm that was extractable with ethyl acetate and was tentatively identified as p-quinone. The conversion of the o-quinone to the corresponding p-quinone was increased at higher H2O2 concentrations (Fig. 2).

                              
View this table:
[in this window]
[in a new window]
 

TABLE 2
Summary of UV spectra data for the dihydroxycinnamic acids oxidation by HRP/H2O2 or tyrosinase/O2 or sodium periodate and their glutathione conjugates


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   Dihydrocaffeic acid metabolism by HRP/H2O2 or tyrosinase/O2.

Addition of sodium borohydride to a solution mixture containing CGA, CA, or DHCA with HRP/H2O2 or tyrosinase/O2, or sodium periodate, reduced the quinones formed. A slight shift of the absorbance maxima to the bathochromic region (a red shift) after metabolism by enzymatic systems and reduction by excess borohydride in comparison with the absorbance maxima of CGA, CA, or DHCA before metabolism probably resulted from the addition of a third hydroxyl group to the aromatic ring (Rinaldi et al., 1995). This red shift in the spectra increased as the pH was increased from 4.0 to 7.4.

Addition of glutathione after 5 min to the mixture of CGA or CA and HRP/H2O2 resulted in the development of a new peak at 275 nm with significant loss in the absorbance of the 250-, 260-, and 420-nm peaks. The 275-nm product was not extractable with ethyl acetate (Table 2). Addition of glutathione after 5 min to DHCA and HRP/H2O2 decreased the absorbance of the 420-nm peak but instead two new peaks at 255 and 490 nm were formed. Similar spectral changes occurred if GSH was present at the beginning of the metabolism reaction.

o-Quinone Stability Kinetics. The stability of the o-quinones formed was found to be related to the pH and followed first order kinetics. The t1/2 stability of the o-quinones formed by each compound decreased with an increase in pH. As shown in Table 1, the t1/2 of o-quinone stability in a decreasing order was CA > DHCA > CGA. The CA o-quinone formed was slightly more stable than the DHCA o-quinone and was almost twice as stable as the CGA o-quinone at pH 7.4.

Dihydroxycinnamic Acids Oxidation Kinetics. As shown in Table 1, the rate of oxidation of dihydroxycinnamic acids by HRP/H2O2 was CA, CGA DHCA. Negligible oxidation (<1 nmol/ml/min) occurred by H2O2 in the absence of HRP. The rate of oxidation of dihydroxycinnamic acids by tyrosinase/O2 in the presence of GSH was DHCA > CGA > CA. Negligible oxidation (<1 nmol/ml/min) occurred in the absence of tyrosinase.

Distribution Coefficient Value. The distribution coefficient measurements for CA, CGA, and DHCA were carried out at pH 4.0 (Table 3). The distribution coefficient value for CGA (50 µM) at pH 4.0 in a mutually presaturated phosphate buffer and 1-octanol solvent system was 1.1 ± 0.1, which means that CGA distributes equally between water and 1-octanol at pH 4.0. The distribution coefficient was higher for DHCA at pH 4.0, which was 3.0 ± 0.4. DHCA, therefore, partitions more into the organic phase than the aqueous phase at pH 4.0. CA with a distribution coefficient value of 14.0 ± 0.1 at pH 4.0, demonstrated a higher organic phase solubility than DHCA or CGA. The distribution coefficients of CA and CGA at pH 7.4 were previously published by Choudhury et al. (1999) as 0.04 and 0.02, respectively. These low distribution coefficients were expected to be due to the ionization of the carboxylic acid moieties at a higher pH.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 3
Distribution coefficients at pH 4.0, and the molar equivalents of GSH depleted as a result of dihydroxycinnamic acid metabolic oxidation

Glutathione Depletion Assay. In the HRP/H2O2 oxidation system, CGA, CA, and DHCA depleted 1.6, 1.8, and 1.9 M equivalents of GSH, respectively, which suggests that 60, 80, and 90% of their mono-glutathione conjugates underwent a second glutathione conjugation, respectively, catalyzed by peroxidase. However, CGA, CA, and DHCA depleted only 1.1, 1.0, and 0.8 M equivalents of GSH in the tyrosinase/O2 oxidation system, respectively, indicating that DHCA was the least suitable substrate for tyrosinase in comparison with CA and CGA. Unlike HRP/H2O2 oxidizing system, the mono-glutathione conjugate of CGA, CA, and DHCA were not substrates for the oxidative enzyme tyrosinase. Negligible GSH depletion (<0.1 M equivalent) occurred in the absence of the enzymes.

Mass Spectrometry Analyses. The glutathione conjugate metabolites were identified by direct injection of the samples into a mass spectrometer (Table 4). Both mono- and bi-glutathione conjugates were identified for CA, DHCA, and CGA when glutathione was present before HRP/H2O2 addition.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 4
Mass spectrometry analyses results for dihydroxycinnamic acid:glutathione conjugates

The mass spectrometry analyses of CGA adducts in HRP/H2O2/GSH system when glutathione was present at the beginning of the reaction revealed signals at m/z [M + 1]+ of 660 and 965, which corresponded to the mono- and bi-glutathione conjugates of CGA, respectively. Similar results were obtained when GSH was added to the reaction mixture after HRP/H2O2, except that the bi-glutathione conjugate was not observed for CGA under the conditions used. Instead, a signal at m/z [M + 1]+ of 371 was detected, which corresponded to a hydroxylated CGA adduct.

CA was also oxidized by HRP/H2O2 to form both mono- and bi-glutathione conjugates with m/z [M + 1]+ of 486 and 791, respectively. A hydroxylated product of CA was also detected at m/z [M + 1]+ of 197 when GSH was added to the reaction mixture 5 min after HRP/H2O2. Mass spectrometry analyses of DHCA when oxidized by oxidative enzymes HRP/H2O2 when GSH was added either before or after the enzyme led to the formation of similar hydroxylated products and mono- and bi-GSH conjugates to that of CGA. A mono-glutathione conjugate of a hydroxylated DHCA adduct with m/z [M + 1] of 504 was also formed (Table 4). In addition DHCA unlike CA and CGA, formed a hydroxylated DHCA adduct with m/z [M + 1]+ of 199 with HRP/H2O2/GSH even when GSH was present before HRP/H2O2 addition.

There was no bi-glutathione conjugate detected for CGA under tyrosinase/O2 oxidation system whether GSH was added first or last but a hydroxylated product and mono-glutathione conjugate of CGA were detected. Similar results were obtained for CA and DHCA. Under all conditions when GSH was present, no CGA-, CA-, and DHCA-dimers or glutathione conjugates of these dimers were formed.

Glutathione Conjugate Formation by Rat Hepatocyte Microsomes. As shown in Table 3, the amount of GSH depleted as a result of dihydroxycinnamic acid oxidation catalyzed by rat liver microsomes/NADPH was determined to be 0.2, 0.5, and 0.6 equivalents of GSH per mole of CGA, CA, and DHCA, respectively. This suggests that only 20, 50, and 60% of the corresponding compounds in the reaction mixture underwent glutathione conjugation. The CGA-, CA-, and DHCA-induced GSH depletion by the microsomes/NADPH metabolic system was largely inhibited by benzylimidazole (a cytochrome P450 inhibitor) (data not shown). Negligible GSH depletion (<0.1 M equivalent) occurred in the absence of NADP+.

Cytotoxicity in Isolated Rat Hepatocytes. As shown in Table 3, the LD50 (2 h) concentrations, determined by trypan blue exclusion technique as a measure of hepatocyte cell membrane intactness and viability, for CA, CGA, and DHCA were 7, 23, and 6 mM, respectively. The cytotoxicity of all three compounds was dose-dependent with a ranking order of DHCA, CA > CGA.

As shown in Table 5, CA was not toxic at 1 mM but became toxic if a nontoxic concentration of hydrogen peroxide (glucose/glucose oxidase system) or cumene hydroperoxide was added. However, this toxicity was prevented by benzylimidazole, a nonspecific P450 inhibitor (Quan et al., 1992), which suggests the involvement of cytochrome P450 in CA metabolism. NADPH/quinone oxidoreductase (NQO) inactivated hepatocytes (using dicumarol as described under Materials and Methods; Preusch et al., 1991) were also markedly susceptible to CA (or 4-propylcatechol), which suggests that CA or 4-propylcatechol were metabolized to toxic quinoid species that could be detoxified by NQO. Furthermore, benzylimidazole abolished CA (5 mM)-induced cytotoxicity. However, catalase-inactivated hepatocytes and GSH-depleted hepatocytes were much more prone to CA. Similar results were also observed for CGA, 4-propylcatechol, and DHCA. Tyrosinase also increased the cytotoxicity of 1 mM caffeic acid.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 5
Caffeic acid-, chlorogenic acid-, and dihydrocaffeic acid-induced cytotoxicity involves metabolic oxidation

Hepatocytes (10 ml) (106 cells/ml) were preincubated at 37°C in Krebs-Henseleit buffer, pH 7.4, with CA and benzylimidazole or hydrogen peroxide (glucose/glucose oxidase system) or cumene hydroperoxide or dicumarol or tyrosinase or sodium azide or bromoheptane (a GSH-depleting agent). Cell viability was determined by trypan blue uptake. Similar experiments were undertaken for CGA and DHCA. Three separate experiments were carried out. Values shown are means ± S.E.

None of the inhibitors (benzylimidazole, dicumarol, sodium azide), hydrogen peroxide-generating system (glucose/glucose oxidase system), hydroperoxides, or tyrosinase alone caused hepatocyte cytotoxicity at the dose given (data not shown).

Hepatocyte GSH Levels. As shown in Table 5, hepatocyte GSH was depleted by the hydroxycinnamic acids with the following order of effectiveness: 4-propylcatechol CGA > CA > DHCA. The GSH levels of NQO-inactivated hepatocytes were also much more readily depleted by DHCA or 4-propylcatechol, which suggests that DHCA or 4-propylcatechol cytotoxicity was caused by a quinoid metabolite that was reductively detoxified be NQO. The cytochrome P450 inhibitor benzylimidazole prevented CA-induced hepatocyte GSH depletion. Similar results were also obtained for CGA, DHCA, or 4-propylcatechol (results not shown) and suggest that these catechols are metabolically activated by cytochrome P450.



    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Using mass spectrometry analyses, we have shown for the first time that mono- and bi-glutathione conjugates were formed when GSH was present during the peroxidase/H2O2-catalyzed oxidation of CA, DHCA, or CGA. Hydroxylated adducts were formed in the absence of GSH or if GSH was added later. This hydroxylation reaction competed with GSH conjugate formation. Metabolism of the dihydroxycinnamic acids by tyrosinase/O2/GSH, however, resulted in the formation of hydroxylated adducts and mono-glutathione conjugates only. Previously, Ploemen et al. (1993) also suggested a glutathione conjugate of CA was formed with the tyrosinase system but did not provide mass spectrometry evidence.

The bi-glutathione conjugates formed with HRP/H2O2 and not with tyrosinase/O2 may be related to differences in the catalytic activity of the enzymes HRP/H2O2 and tyrosinase/O2 as well as the differences in the oxidation mechanisms of the two enzymes. Peroxidase catalyzes a one-electron oxidation of catechols (Nakamura et al., 1985, 1989; Garcia-Moreno et al., 1999; Espin et al., 2000), whereas tyrosinase oxidizes catechols through a two-electron oxidation mechanism, thus bypassing the short-lived semiquinone intermediate (Passi and Nazzaro-Porro, 1981; Espin et al., 2000).

Although the mass spectrometry analyses do not show the pattern of glutathione conjugation, it is easy to predict the pattern for the formation of a mono-glutathione conjugate of dihydroxycinnamic acids. C-2 and C-5 of the aromatic ring of CA, CGA, or DHCA o-quinones are almost equally electrophilic reactive centers because they are adjacent to the carbonyl groups of the o-quinone formed, whereas the C-6 is the least electrophilic center (Fig. 3). However, what distinguishes the three electrophilic centers is the sterical hindrance in an increasing order of C-5 < C-6 < C-2. We have recently reported 1H NMR data on the mixture of three possible isomers of mono-glutathione conjugate of catechin even though the isolation and purification of each mono-glutathione conjugate of catechin was not possible (Moridani et al., 2001). Using the integration of the protons, chemical shifts, and coupling constants for 1H NMR on protons of the B-ring of catechin glutathione conjugate metabolite, we found that the sterical hindrance was playing a major role as a distinguishing factor for glutathione to attack C6' electrophilic center more readily than C-2', despite the fact that C-2' is more electrophilic than the C-6' center in catechin. The C-5' center is the most electrophilic and the least sterically hindered center and therefore it does not come as a surprise that its glutathione conjugate derivative M1 was formed 1.5- and 3-fold more than the other two metabolites M2 and M3 (Fig. 3). Therefore, we have concluded that we could have a similar pattern for the mono-glutathione conjugates of CA, CGA, or DHCA except that C-2 on dihydroxycinnamic acids is less crowded than C-2' on catechin. This might lead to the different amounts of M2 and M3 formation found for dihydroxycinnamic acids.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3.   Pattern for the mono-glutathione conjugate formation of dihydrocaffeic acid and catechin.

Spectral evidence of a transient o-quinone intermediate for CA, CGA, and DHCA was obtained at pH 4 by using HRP/H2O2-metabolizing system. These intermediate products reacted rapidly with glutathione or underwent addition by H2O. Further oxidation of this hydroxylated adduct by O2 formed a p-quinone. The immediate product formed during enzymatic oxidation had a peak at 250 nm and shoulder at 260 nm, which could be attributed to the formation of the o-quinone and the p-quinone, respectively. Evidence for this finding came from the addition of excess potassium borohydride that caused the disappearance of 250- and 260-nm peaks, o-quinone and p-quinone, respectively, and the reformation of CGA or CA or DHCA. The 250- and ~420-nm peaks observed for CGA, CA, and DHCA were tentatively postulated as an o-quinone product because the starting material (i.e., a catechol structure) was formed upon the addition of borohydride. The red shift observed in the UV spectra of CA, CGA, or DHCA after metabolism by HRP/H2O2 enzyme and reduction with borohydride could be attributed to the introduction of the third hydroxyl group to their aromatic rings. Similar results were found for CA, CGA, and DHCA with the tyrosinase/O2 oxidation system. Previously, it was shown that the oxidation of 4-t-butylcatechol with HRP/H2O2 also formed the characteristic o-quinone peak at 420 nm (Garcia-Monreno et al., 1999). Oxidation of CGA by hypochlorite also led to the formation of peaks at 420 and 490 nm, which were suggested to be o-quinone or p-quinone, respectively (Kono et al., 1995).

Hydroxylation of catecholic compounds was previously reported as a result of p-coumaric oxidation to CA by spinach-beet phenolase (McIntyre and Vaughan, 1975). Upon potassium borohydride addition to the tyrosinase or peroxidase enzymatic oxidation products of CGA, CA, or DHCA, spectral evidence for the formation of hydroxylated products of CGA, CA, and DHCA was obtained. Mass spectrometry analyses confirmed this. Previously, it was suggested that water or H2O2 could add or hydroxylate, respectively, certain noncyclizable o-quinone (Napolitano et al., 1995; Jimenez and Garcia-Carmona, 1996). The conversion of the hydroxylated product of CGA, CA, and DHCA to the corresponding p-quinone probably resulted from auto-oxidation (Fig. 2) because the hydroxylated products are likely to have a higher oxidation potential than the hydroxycinnamic acids.

DHCA o-quinone can also undergo an intramolecular cyclization to form dihydroesculetin (Fig. 2) (Sugumaran et al., 1989). CA o-quinone, however, cannot undergo cyclization due to the presence of the trans double bound. Furthermore, CGA is also unable to cyclize due to the lack of nucleophilic carboxyl group on its side chain in a short vicinity to the o-quinone ring. However, esculetin, the cyclized product of CA, was found when rat livers were perfused with CA (Gumbinger et al., 1993). Under our experimental conditions, esculetin was not identified as a product of CA oxidation by tyrosinase although we have found that isolated rat hepatocytes could convert CA to DHCA (data not shown).

CA, CGA, or DHCA were also found to be substrates for the NADPH-supported microsomal cytochrome P450 system and resulted in glutathione conjugate formation. Because CA, CGA, or DHCA had a partition coefficient value of greater than one, we hypothesize that they can cross the isolated rat hepatocyte membrane and are metabolized by P450 to form a cytotoxic o-quinone. However, there is no obvious immediate correlation between LD50 and log P, whereas there is a correlation between LD50 and distribution coefficient values measured at pH 4 or calculated for pH 7.4; the higher the distribution coefficient the more toxic the compounds (Table 3). We also showed for the first time that CA, CGA, and DHCA were metabolically activated by cytochrome P450 peroxygenase activity (Anari et al., 1997a,b). Further evidence that the cytotoxic metabolite is probably an o-quinone is the marked increase in hepatocyte susceptibility to CA, CGA, and DHCA if NQO1 was inhibited. Most of the quinone substrates of NQO1 are p-quinones but two o-quinones, 9,10-phenanthrenequinone and cyclized dopamine o-quinone, have also been shown to be NQO1 substrates (O'Brien, 1991; Segura-Aguilar et al., 1992).

Tyrosinase is often abundant in melanoma and therefore can be considered as a useful enzyme for bioactivating CA, CGA, and DHCA if used for antimelanoma therapy. Enzyme-directed antimelanoma therapy includes the use of phenols or catechols that form o-quinones that are highly toxic to tyrosinase-containing melanoma tumor cells (Riley et al., 1997). Quinones are highly reactive species that can react with a variety of nucleophiles such as water, thiol-containing compounds, amino acids, and protein thiols, which are normally found in the cell. Glutathione is an important mechanism for cellular defense against reactive quinones (O'Brien, 1991). However, it needs to be shown that CGA, CA, and DHCA act as a substrate for melanoma tyrosinase and depletes GSH and protein thiols in the melanoma cells, resulting in cell death.

    Acknowledgments

We thank Dr. Ling-Jie Meng (Medical Sciences Building, University of Toronto, ON, Canada) for the assistance received with mass spectrometry analyses, Ford Barker for excellent skills in the preparation of isolated rat hepatocytes, and Kristin Beard for technical assistance in GSH and GSSG measurement by using HPLC technique.

    Footnotes

Received April 25, 2001; accepted July 23, 2001.

This work was financially supported by a grant received from the Natural Sciences and Engineering Research Council of Canada.

Dr. Peter O'Brien, 19 Russell St., Faculty of Pharmacy, University of Toronto, ON, Canada M5S 2S2. E-mail: peter.obrien{at}utoronto.ca

    Abbreviations

Abbreviations used are: CGA, chlorogenic acid; CA, caffeic acid; DHCA, dihydrocaffeic acid; P450, cytochrome P450; HRP, horseradish peroxidase type I; HPLC, high-performance liquid chromatography; GSH, glutathione; DETAPAC, diethylenetriaminepentaacetic acid; DTNB, 5,5'-dithio-bis(2-nitrobenzoic acid); UV-VIS, UV-visible; GSSG, glutathione disulfide (oxidized glutathione); NQO, NADPH/quinone oxidoreductase.


    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0090-9556/01/2911-1432-1439
DMD, 29:1432-1439, 2001
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
W. Lu and J. P. Uetrecht
Peroxidase-Mediated Bioactivation of Hydroxylated Metabolites of Carbamazepine and Phenytoin
Drug Metab. Dispos., August 1, 2008; 36(8): 1624 - 1636.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moridani, M. Y.
Right arrow Articles by O'Brien, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moridani, M. Y.
Right arrow Articles by O'Brien, P. J.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition